CHEMISTRY AND ANTITUMOUR ACTIVITY OF 5-BROMOURACILE’S DERIVATIVES

Elena Welchinskaya

Abstract


Problemofthetreatmentof man’scancerandsearchoftheeffective, withalittletoxicityantitumourmedicalproducts,isonefromtheimportant taskatthecontemporaneous medicine and pharmaceutical chemistry. Chemicalmodificationofmolecularof5-bromouracilewithnextinvestigationoftoxicity and antitumour activityofits newderivativeswhichsynthesized is described. Physical-chemical, statistical pharmacological, toxicological methods were used. A strongly antitumour effect has been discovered for bis-derivative of 5-bromouracile for the first time. A new convenient methods for the preparation of new mono- and bis-derivatives of 5-bromouracile with 1,1,1-trifluoro-2-bromo-2-chloroethane (ftorotan) and 1,1-diethylcarboxy-2-chloro-2-trifluoromethylethylene is described. The reactions are catalyzed by the DB-18-crown-6-complex. It was tested on the heterotransplantates of man’s glioma cancer of brain (by Bogden’s under capsule-method). It is permits to consider the new bis-derivative of 5-bromouracile as physiological active with a perspective investigation as potential antitumour drugs for treatment of man in future.


Full Text:

PDF

References


Adjei, A. A. (1999). Review of pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer. Clinical Pharmacology, Vol. 48, p. 265-277.

Abou – Gharbia, M. & Patel – Usha, R. (Eds.). (1988). Polycyclic aryl- and heteroarylpiperazinyl imides as 5-HT1A receptor ligands and potential anxiolytic agents: synthesis and structure-activity relationship studies. Journal of Medical Chemistry, Vol. 31 (7), p. 1382-1385.

Аlоnso, R., Shaw G. & Wright D. (1984). Thermal addition of heterocycles to bicyclic reagents. Journal Chemical Society Perkin Translation, l (12), p. 2795-2799.

Anderson, N. & Lokich, J. (1992). Controversial issues in 5-fluorouracil infusion use. Dose intensity, treatment duration, and cost comparisons. Cancer, 70, p. 998-1002.

Anttila, M. I., Sotaniemi, E. A. & Kairaluoma, M. I. (Eds.). (1983). Pharmacokinetics of ftorafur after intravenous and oral administration. Cancer Chemotherapy and Pharmacology, 10, p. 150–153. http://dx.doi.org/10.1007/BF00255750

Au, J. L., Wu, A. T. & Friedman, M. A. (Eds.) (1979). Pharmacokinetics and metabolism of ftorafur in man. Cancer Treatment Rep., 63, p. 343–350.

Baba, H., Kohnoe, S. & Endo, K. (Eds.) (2000). State of the treatment for gastrointestinal cancer. Gan To Kagaku Ryoho., Vol. 27, p. 1233-1246.

Barlow, R. (1959). Vvedenie v himicheskyy farmacologiy [Introduction to chemical pharmacology]. Moscow, Russia: Foreign literature.

Benz, C., Tills, T. & Tattelman, E. (Eds.) (1982). Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer. Cancer Research, Vol. 42, p. 2081-2086.

Brody, G. L. & Sweet, R. B. (1963). Halothane anesthesia as a possible cause of massive hepatic necrosis. Anesthesiology, Vol. 24, p. 29–37. http://dx.doi.org/10.1097/00000542-196301000-00005

Brown, B. R. & Sipes, I. G. (1977). Biotransformation and hepatotoxicity of halothane. Biochemical Pharmacology, Vol. 26, p. 2091–2094. http://dx.doi.org/10.1016/0006-2952(77)90256-8

Longley, D. B. & Harkin, D. P. (2004). Mechanisms of action of 5-fluorouracil. Nature Revues Cancer, Vol. 4, p. 230-238.

Noordhuis, P. & Holwerda, U. (2004). 5-fluorouracil incorporation info RNA and DNA in relation to thymidilate synthetase inhibition human colorectal cancer. Annals of oncology, Vol. 15, p. 1025-1032. http://dx.doi.org/10.1093/annonc/mdh264 PMid:15205195

Perevodchikovoy, N. I. (Ed.) (2005). Chimioterapia rakovih zabolevaniy [Chemotherapy of cancerous diseases] (2nd edition). Moscow, Russia: Practical medicine.

Prozorovskiy, V. B., Prozorovskiy, V. P. & Demchenko, V. М. (1978). Ekspress-metod opredeleniya sredney effektivnosty dozy i ego oshibka [Express - method of middle effective dose determination and its mistake]. Pharmacology and toxicology, Vol. 41 (4), p. 407-509.

Sophinoy, Z. P., Sophina, A. B., Goldina, A. & Kmeina, A. (Eds.) (1979). Eksperimentalnay ocenka protivoopuholevyh preparatov v SSSR i SShA [The experimental value of the antitumour drugs in USSR and USA]. Moscow, Russia: Medicine.

Welchinska, H. V., Piecuszak, B. I. & Kovalenko, E. A. (Eds.) (2003). Biologicheskaya aktivnost bakterialnih lektinov i ih molekularnih kompleksov s geterotsyklicheskimy bis-adduktamy [Biological activity of bacterial lectins and their molecular complexes with heterocyclic bis-adducts]. Microbiological journal, Vol. 65 (6), p. 20-25.

Yagupolskiy, L. M. (1988). Aromaticheskie i geterocyklicheskie soedineniya s ftorsoderjashimy zamestitelyamy [Aromatic and heterocyclic compounds with fluorocontaining substitutes]. (p. 90–105). Kiev, Ukaine: Naukova dumka.




DOI: http://dx.doi.org/10.12955/cbup.v1.45

Refbacks

  • There are currently no refbacks.


Print ISSN 1805-997X, Online ISSN 1805-9961

(c) 2017 Central Bohemia University